general anaesthesia 1

Upload: karuna-dewalwar

Post on 06-Apr-2018

217 views

Category:

Documents


1 download

TRANSCRIPT

  • 8/3/2019 General Anaesthesia 1

    1/46

    GENERAL ANAESTHESIA

    Presented by

    Dr. Vishal DewalwarLecturer

  • 8/3/2019 General Anaesthesia 1

    2/46

    Definition

    A controlled state of unconsciousness

    in which there is a loss of protective

    reflexes, including the ability to

    maintain an airway independently and

    to respond appropriately to physicalstimulation. or verbal command.

  • 8/3/2019 General Anaesthesia 1

    3/46

    Surgery Before Anesthesia

  • 8/3/2019 General Anaesthesia 1

    4/46

    Fun and Frolic led to early Anaesthesia

  • 8/3/2019 General Anaesthesia 1

    5/46

    History of Anaesthesia

    Joseph Priestlydiscovered N2O in 1773

    Sir Humphrey Davyexperimented with

    N2O, reported loss of pain, euphoria

    Horace Wells in 1844 demonstrated N2O

    for tooth extraction

  • 8/3/2019 General Anaesthesia 1

    6/46

    William Morton, dentistfirst

    demonstration of successful surgical

    anesthesia with ether in 1846

    Dr. John Snow administered chloroform to

    Queen Victoria (1853)popularized

    anesthesia for childbirth in UK

  • 8/3/2019 General Anaesthesia 1

    7/46

    Goals of Anaesthesia

    Hypnosis (unconsciousness)

    Amnesia

    Analgesia Immobility/decreased muscle tone

    (relaxation of skeletal muscle)

    Inhibition of nociceptive reflexes Reduction of certain autonomic reflexes

    (gag reflex, tachycardia, vasoconstriction)

  • 8/3/2019 General Anaesthesia 1

    8/46

    Preanaesthetic evaluation

    The main purpose of preoperative visit is to

    assess the patients fitness for anaesthesia.

    This visit allows the most suitable

    anaesthetic technique to be determined, any

    potential interaction between concurrentdiseases, drugs and anaesthesia to be

    anticipated and also provides reassurance to

    the patient.

  • 8/3/2019 General Anaesthesia 1

    9/46

    Anaesthetic History

    Previous anaesthesia and major surgeries

    Past and present medical history

    - CVS, RS

    - Pregnancy

    Drug and allergies Personal history

    - HabitsSmoking, Alcohol, Drugs

  • 8/3/2019 General Anaesthesia 1

    10/46

    Physical Examination

    Cardiovascular System

    - Cardiac arrhythmias

    - Blood pressure

    - Peripheral veins

    Respiratory System

    - Asthma

    - COPD`s

  • 8/3/2019 General Anaesthesia 1

    11/46

    Nervous system

    - motor or sensory impairment

    Musculoskeletal system

    - TMJ- Cervical spondilitis

  • 8/3/2019 General Anaesthesia 1

    12/46

    Airway

    - assessment is made in 3 stages

    1. Observation of patients anatomy

    2. Bedside tests

    3. X- rays

  • 8/3/2019 General Anaesthesia 1

    13/46

    1. Observation of patients anatomy- Trismus

    - Retrognathia

    - Position, no. and health of teeth- Size of tongue

    - Deviated larynx or trachea

    - Midline or lateral swelling of neck

  • 8/3/2019 General Anaesthesia 1

    14/46

    2. Bedside tests

    a. Mallampati`s criteria

    - view of pharyngeal

    structures is noted

    and graded as I-IV

  • 8/3/2019 General Anaesthesia 1

    15/46

    b. Thyromeatal distance

    - distance between

    bony point of the chin

    and the prominence ofthyroid cartilage

    - a distance less than

    7cm suggests difficult

    intubation

  • 8/3/2019 General Anaesthesia 1

    16/46

    3. X - rays

    - Lateral and AP neck X - rays are advised

    - measurements can be made on lateral

    X - ray of head and neck

  • 8/3/2019 General Anaesthesia 1

    17/46

    Preanaesthetic medication

    It refers to the drugs administered to facilitate theinduction and maintenance of anaesthesia.

    The 6 A`s premedication1.Anxiolysis

    2.Amnesia

    3.Anti-emetic

    4.Antacid

    5.Anti-autonomic

    6.Analgesic

  • 8/3/2019 General Anaesthesia 1

    18/46

    Aims

    1. Relief of anxiety and apprehension

    preoperatively and to facilitate smooth

    induction.

    2. Amnesia for pre and post operative events.

    3. Supplement analgesic action of

    anaesthetics and potentiate them so thatless anaesthetic is needed.

  • 8/3/2019 General Anaesthesia 1

    19/46

    3. Decrease secretions and vagal stimulationcaused by anaesthetics.

    4. Antiemetic effect extending to the

    postoperative period.

    5. Decreases acidity and volume of gastric

    acid so that it is less damage if aspirated.

  • 8/3/2019 General Anaesthesia 1

    20/46

    Anticholinergics

    ATROPINE

    Atropine is the prototype drug of anticholinergic class and is

    highly selective for muscarinic receptors.

    ACTION:-Blocks the muscarinic effects of acetylcholine as it has

    the same affinity for muscarinic receptors as

    acetylcholine but poor intrinsic activity.

    USES :- 1. Preanasesthetic medication

    2.Organophosphorous poisoning

    3.Bradyarrhythmias

    4.Motion sickness

    5.Colic and dysmenorrehea

  • 8/3/2019 General Anaesthesia 1

    21/46

    SIDE EFECTS :-1.Dry mouth, dysphagia, constipation, paralytic ileus

    2.Urinary retention

    3.Blurred vision and precipitates of glaucoma

    4.Allergic dermatitis

    PRECAUTIONS:-1.In elderly it precipitates glaucoma and urinary

    retention(if enlarged prostate).

    2.In chronic lung diseases it dries up secretions.

    DOSE :-ATROPINE SULPHATE 0.6mg/ml inj. i.m.,i.v.

    6.Peptic ulcer

    7.Parkinson`s disease

    8.To produce mydriasis and cycloplegia

  • 8/3/2019 General Anaesthesia 1

    22/46

    RANITIDINE

    It is introduced as a non-imidazole H2 blocker.

    ACTION:-1. Abolishes histamine stimulated gastric acid secretion

    and flushing.

    2. Inhibits gastric H2 receptors, this reduces basal, 24 hours

    and nocturnal acid secretion.

    3. Has mucosal protective action.

    USES:- 1.Preaneasthetic medication.

    2.Peptic ulcer.

    3.Esophagitis.

    H2 BLOCKER

  • 8/3/2019 General Anaesthesia 1

    23/46

    6.Gastro oesophageal reflux disease(GERD).

    SIDE EFFECTS :- 1.Blood dycrasias.

    2.Skin rash.

    3.Leucopenia

    DOSE :-300mg/day or 150mg BD

    50mg i.m. or slow i.v.every 6 to 8 hrs.

    TRADE NAME :- ULTEC,ZENTAC,RANITINE,ACILOC.

    4.Stress ulcer

    5.Zollinger- Ellision syndrome

  • 8/3/2019 General Anaesthesia 1

    24/46

    ONDANSETRON

    It is the prototype of a new class of anti emetic drugs developed tocontrol cancer chemotherapy/radiotherapy induced vomitting and later

    found to be highly effective in postoperative nausea and vomiting as

    well.

    USES:- 1.Preaneasthetic medication.

    2.It is given before starting chemotherapy

    especially CISPLASTIN.

    SIDE EFFECTS:- 1.GI:diarrohea

    .

    ANTIEMETIC

  • 8/3/2019 General Anaesthesia 1

    25/46

    DOSE : 4-8mg BD or TDS orally or i.v.

    TRADE NAME:-EMESET,VOMIZ,OSETRON

    2.Skin:rashes

    3.Miscellaneous;headache, blurred vision,

    hypokalemia, anaphylactoid reaction.

  • 8/3/2019 General Anaesthesia 1

    26/46

    INTRAVENOUS ANAESTHETICS

    INTRAVENOUS

    Inducing agents Slower acting drugs

    Thiopentone sodium Benzodiazepines

    Propofol Diazepam

    Midazolam

    Dissociative anaesthesia

    Ketamine

  • 8/3/2019 General Anaesthesia 1

    27/46

    Inducing agents

    These are drugs which on i.v. injection

    produce loss of consciousness.

    They are generally used for induction

    because of rapidity of onset of action.

  • 8/3/2019 General Anaesthesia 1

    28/46

    THIOPENTONE SODIUM

    It is an ultra short acting barbiturate highly soluble in water.

    It must be prepared freshly before injection.

    ACTION :- Its undissociated form has high lipid solubility & enters

    brain almost instantaneously to produce unconsciousness

    in 15-20 sec & last till 10-20 min.

    USES :- 1.Inducing agent along with anaesthetic.

    2. Rapid control of convulsions.

    3. Gradual i.v. infusion of subanaesthetic doses can be

    used to facilitate verbal communication with psychiatric

    patient.

  • 8/3/2019 General Anaesthesia 1

    29/46

    ADVERSE EFFECTS:- 1. Laryngosparm when respiratory secretions

    or other irritants are present.

    2. Shivering & delirium.3. Post operative pain.

    CONTRAINDICATION:- Acute intermittent porphyria.

    N.B. :- Succinylcholine & thiopentone react

    chemically should not be mixed in the

    same syringe.

    DOSE :- 3-5 mg/kg as a 2.5% solution.

    TRADE NAME :- PENTOTHAL, INTRAVAL SODIUM.

    PROPOFOL

  • 8/3/2019 General Anaesthesia 1

    30/46

    PROPOFOL

    It is an oily liquid introduced recently as a 1% emulsion for i.v.

    induction & short duration anaesthesia.

    ACTION :- Unconsciousness after propofol injection occurs in

    15-45sec & lasts for 15min.

    USES :- 1.Inducing agent; particularly for out patient

    surgery.

    2. In subaneasthetic doses; used for sedation in

    intensive care units.

    SIDE EFFECTS :- 1. Pain during injection.

    2. Dose dependent respiratory depression.

    DOSE :- 2mg/kg bolus i.v. for induction

    9mg/kg/hr for maintenance.

  • 8/3/2019 General Anaesthesia 1

    31/46

    SLOWER ACTING DRUGS

    BENZODIAZEPINES

    In addition to preanaesthetic medication; BZDs are now frequentlyused for inducing, maintaining and supplementing anaesthesia.

    ACTION :-Injected i.v. produce sedation, amnesia and thenunconsciousness in 10-15 minutes. If no other

    anaesthetic or opioid is given, the patient becomes

    responsive in 1 hr but amnesia persists for 2-3 hr

    and sedation for 6 hr or more.

    USES :-1. Sedative and Hypnotic.

  • 8/3/2019 General Anaesthesia 1

    32/46

    2. Muscle Relaxant

    3. Preanaesthetic Medication

    4. Alcohol Withdrawal

    5. Anxiety Neurosis

    6. Petit-mal, Psychomotor and Status Epilepticus.SIDE EFFECTS:- 1. Drowsiness

    2. Ataxia

    3. Respiratory Depression4. Hypotension

  • 8/3/2019 General Anaesthesia 1

    33/46

    MIDAZOLAM

    Water Soluble

    Non IrritatingFaster and Shorter Acting

    3 Times more potent than Diazepam

  • 8/3/2019 General Anaesthesia 1

    34/46

    KETAMINE

    It induces a so called Dissociative Anaesthesia

    - profound analgesia,immobility, amnesia with light sleep and feeling of dissociation from

    ones own body and the surroundings.

    ACTION:- It acts within a minute and recovery starts after 10-15

    minutes, but patient remains amnesic for 1-2 hrs.

    USES :-1.Recommended for Operations on head and neck.

    2.In patients who have bled.

    3.In Asthmatics (relieves bronchopasm).

    4.In burn dressings.

  • 8/3/2019 General Anaesthesia 1

    35/46

    SIDE EFFECTS :- 1. Emergence Delirium

    2. Hallucinations

    3. Involuntary Movements

    DOSE :- 1-4(average 2)mg/kg i.v. or

    6.5-13(average10)mg/kg i.m.

    TRADE NAME :- KETAMIN, KETLAR.

  • 8/3/2019 General Anaesthesia 1

    36/46

    SKELETAL MUSCLE RELAXANTS

    Skeletal muscle relaxants are drugs that act peripherally at the neuro

    muscular junction/muscle fibre itself or centrally in the cerebrospinal

    axis to reduce muscle tone and/or cause paralysis.

    Peripherally acting Centrally acting

    muscle relaxants muscle relaxants

    *Non Depolarizing blockers *Mephenesin group

    Pancuronium Chlorzoxazone

    d-Tubocurarine *Benzodiazepines

    *Depolarizing blockers Diazepam and others

    Succinylcholine *GABA Derivative

    Baclofen

    Comparative features of central and peripheral muscle relaxants:-

  • 8/3/2019 General Anaesthesia 1

    37/46

    Comparative features of central and peripheral muscle relaxants:

    Centrally acting Peripherally acting

    1.Decrease muscle tone without 1.Cause muscle paralysis,

    reducing voluntary action. Voluntary movements lost.

    2.Selectively inhibit polysynaptic 2.Block neuromuscular

    reflexes in CNS. transmission.

    3.Cause CNS depression. 3.No effect on CNS.

    4.Given orally sometimes 4.Practically always given

    parenterally. i.v.

    5.Used in chronic spastic condition, 5.Used for short term purposes

    acute muscle spasms,tetanus. (surgical procedures).

  • 8/3/2019 General Anaesthesia 1

    38/46

    MECHAISM OF ACTION

    NON-DEPOLARIZING BLOCKERS(COMPETITIVE)-

    They combine with the receptors on the motor end-plate and thus

    block the action of acetylcholine by competitive blockade.

    DEPOLARIZING BLOCKERS(NON-COMPETITIVE)-

    Depolarize muscle end-plates by opening Na-channels & thus act as

    partial agonist of acetylcholine.

  • 8/3/2019 General Anaesthesia 1

    39/46

    SUCCINYLCHOLINE

    Commonly used muscle relaxant for passing tracheal tube.

    Induces rapid, complete and predictable paralysis with

    spontaneous recovery in 5min.

    DOSE :- 50mg/ml injection, 2ml ampule.

    TRADE NAME:- MIDARINE.

  • 8/3/2019 General Anaesthesia 1

    40/46

    PANCURONIUM

    Synthetic steroidal compound.

    Provides good cardiovascular stability.

    Seldom induces flushing, bronchospasm or cardiac arrhythmias.

    Relatively inexpensive.

    Reversal often required due to its long duration of action.

    DOSE :- 2mg/ml in 2ml amp.

    TRADE NAME:- PAVULON, PANCONIUM.

  • 8/3/2019 General Anaesthesia 1

    41/46

    ATRACURIUM

    4 times less potent than pancuronium & shorter acting.

    Inactivation in plasma by spontaneous non-enzymatic degradation

    (HOFFMANN ELIMINATION).

    DOSE :- 10mg/ml injection in 2.5ml vial.

    TRADE NAME:- TRACRIUM.

    ANALGESICS

  • 8/3/2019 General Anaesthesia 1

    42/46

    ANALGESICS

    DICLOFENAC SODIUM

    It is non-opioid analgesic , anti-pyeretic non-steroidal

    anti-inflammatory drug.

    ACTION :- It inhibits synthesis and has short lasting

    antiplatelet action.

    USES :-1. Post-traumatic and postoperative

    inflammatory conditions-affords quick relief ofpain and edema.

    2. Rheumatoid & osteoarthritis, bursitis.

    3. Ankylosing spondylitis.

  • 8/3/2019 General Anaesthesia 1

    43/46

    SIDE EFFECTS :-1.Epigastric pain, nausea.

    2.Headache, dizziness,rashes.

    DOSE :- 50 mg TDS

    75 mg deep i.m.

    TRADE NAME :- VOVERAN, DICLONAC.

  • 8/3/2019 General Anaesthesia 1

    44/46

    PENTAZOCINE

    It is the first opioid agonistantagonist to be used as an analgesic.

    ACTION :- 1. Raises pain threshold & modifies

    emotional reaction to pain.

    2.Inhibits transmission of impulses across

    the pain pathways in CNS.

    USES :-1. Potent analgesic with low addiction

    liability.

    SIDE EFFECTS :- 1. Respiratory depression.

    2. Hallucinations and unpleasant dreams.

    3. Pulmonary & systemic hypertension.

  • 8/3/2019 General Anaesthesia 1

    45/46

    DOSE :- 50-100 mg orally.

    30-60 mg i.m. , s.c.

    TRADE NAME :- FORTWIN, MERIWYN, SOSEGON.

  • 8/3/2019 General Anaesthesia 1

    46/46

    THANK YOU